Clinical Trial Update: Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating pembrolizumab with a monoclonal antibody therapy in advanced cancers; study TERMINATED with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cancer
• Colorectal Cancer
• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Western Regional Medical Center | Conditions: Advanced Cancer, Breast Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2018-11-02